Sol Endocrinology Helps Dallas Patients Find Their Best Fit in Diabetes Technology With Free DiabetesWise Tool

Practice introduces patients on insulin pumps, CGMs, and automated insulin delivery systems to a free, Stanford-built resource.

DALLAS, TX, UNITED STATES, August 11, 2026 /EINPresswire.com/ -- Sol Endocrinology, under the direction of Dr. Erin Roe, is now guiding patients toward DiabetesWise (diabeteswise.org), a free, independent website developed by researchers at Stanford University to help people with diabetes choose the insulin delivery and glucose monitoring devices that best fit their lives.

Diabetes technology has expanded well beyond fingersticks and syringes. Continuous glucose monitors (CGMs) now provide real-time readings and trend alerts, while insulin can be delivered through pens, syringes, an insulin pump, or an automated insulin delivery (AID) system that adjusts background insulin automatically. With so many options, patients and their care teams increasingly need a shared way to sort through what actually fits a given person's routine, comfort level, and budget.

“There isn’t one right device for everyone — there’s a right device for each patient,” said Dr. Erin Roe. “DiabetesWise gives our patients a clear, judgment-free way to think through their options before they even walk into the office, so the time we spend together goes further.”

The site walks users through a short guided check-in, offers plain-language profiles of every major device category, and features first-person videos from real people with diabetes describing why a device worked — or didn’t — for them. It also helps patients think through insurance and Medicare coverage and prepares a personalized summary to bring to their next appointment.

Sol Endocrinology emphasizes that clinical evidence and personal fit go hand in hand. For patients with type 1 diabetes, AID systems generally produce better glucose outcomes than a pump or injections alone, and CGM use is now considered standard of care. For type 2 diabetes, CGM has been shown to improve A1C for many patients, including some not on insulin, and several AID systems are now approved for type 2 use as well. Coverage and eligibility still vary by insurance plan, and the practice works directly with patients to confirm what their specific plan allows.

Patients are encouraged to complete the free 10–15 minute check-in at diabeteswise.org before their next visit, note their top device options and concerns, and bring that list to their appointment for a coverage review and, where appropriate, hands-on training.

About Sol Endocrinology

Sol Endocrinology, led by Dr. Erin Roe, provides comprehensive endocrine and diabetes care in Dallas, Texas. The practice is committed to helping patients navigate the full range of modern diabetes technology and treatment options as part of individualized, ongoing care.

Dr. Erin Roe
Sol Endocrinology
+1 469.648.3636
admin@sol-endo.com
Visit us on social media:
Instagram
Facebook